SJC upholds $63 million Children’s Motrin verdict

Thursday, Apr. 23, 2015
Article Picture

On April 17, the Supreme Judicial Court agreed with the Massachusetts Bar Association and Massachusetts Medical Society when it affirmed a $63 million Children's Motrin verdict in a case where a young child developed toxic epidermal necrolysis after receiving multiple doses of the over-the-counter painkiller. The SJC found that Johnson & Johnson's warning claim is not preempted and that the awards for the victim and her parents were not excessive.

To see the amicus brief filed on behalf of the MBA and Mass. Medical Society, click here.